Meridian Bioscience, Inc. Reports Record Second Quarter and Six Months Operating Results, Splits Stock 3 for 2, and Increases Dividend

CINCINNATI--(BUSINESS WIRE)-- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today: reported record second quarter and six months net sales of $32,094,000 and $60,814,000, respectively, an increase of 14% over the same periods of the prior fiscal year; reported record second quarter and six months net earnings of $5,881,000 and $11,445,000, respectively, an increase of 25% and 32% over the same periods of the prior fiscal year;